01

Oct

2020

18:00

BST

Webinar

Impacting MR and TR Patient Outcomes with the PASCAL Repair System

Average (ratings)
No ratings
Your rating

Overview

This studio-based interactive broadcast will bring together a world-leading faculty for a series of presentations, engaging discussions and a live case, led by Prof Lurz from the renowned Heart Center Leipzig, in which he will demonstrate the PASCAL repair system for the treatment of Mitral Regurgitation. Whilst the focus will be on MR treatment, our faculty will also offer expert insight to TR treatment.

Moderated by Prof Nicolas Van Mieghem, from Erasmus Medical Center, Rotterdam, this dynamic event will keep its audience central to proceedings with the chance to engage with the faculty throughout with live Q&As, and polls to share the latest audience insights to the challenges, opinions and approaches in mitral and tricuspid valve disease repair.

Pipeline products from Edwards Lifesciences will also be shown.

Faculty:


Fabien Praz

Fabien Praz


Dr Sinisa Markovic

Dr Sinisa Markovic


Dr Edith Lubos

Dr Edith Lubos


Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben


Philipp Lurz

Philipp Lurz


Nicolas M Van Mieghem

Nicolas M Van Mieghem

This webinar is supported by

Agenda

Presentation: Where are We Now with the Treatment of Mitral & Tricuspid Regurgitation?

Prof van Mieghem

Presentation: Residual MR Matters

Dr Praz

Presentation: 1-year CLASP Study Outcomes and Real World Experience with the PASCAL Repair System for MR

Dr Lubos

Discussion

All

Presentation: Leveraging the PASCAL Repair System Technology to Treat TR

Dr von Bardeleben

Presentation: Clinical Evidence with the PASCAL Repair System on the Treatment of TR

Dr von Bardeleben

Discussion

All

Presentation: PASCAL Repair System for TR - Case Presentationss

Dr Markovic

Discussion

All

LIVE Case - PASCAL Mitral

Prof Lurz

Summary - Session evaluation and key learnings

Prof van Mieghem

Learning Objectives

  • To show latest evidence and developments on what is new in mitral and/or tricuspid valve disease repair
  • To discuss the clinical evidence of PASCAL repair system in the treatment of MR and TR
  • To learn from case examples how PASCAL repair system improves outcomes of patients with TR
  • To enhance practical learning through a step-by-step LIVE demonstration of percutaneous mitral leaflet repair with PASCAL repair system

Faculty Biographies


Fabien Praz

Fabien Praz

Dr Fabien Praz is an interventional cardiologist at Bern University Hospital, Switzerland. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Stenosis, and Aortic Valve Stenosis.

View full profile

Dr Sinisa Markovic

Dr Sinisa Markovic

University Clinic Ulm, Germany

View full profile

Dr Edith Lubos

Dr Edith Lubos

University Medical Center Hamburg-Eppendorf, Germany

View full profile

Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany 

Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.

He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.

View full profile

Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Director of the Department of Cardiology Universitätsmedizin Mainz, Germany. Prior to this, he served as Deputy Head of the Department at Heart Center Leipzig, Germany. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.

View full profile

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Prof Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

As well as his involvement in percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals. Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.

 Prof Van Mieghem is on the ICR3 Editorial Board.

 

View full profile